Back
Protalix BioTherapeutics Quote, Financials, Valuation and Earnings
This DeFi Coin Could 10x Soon... I Advise You Get In Now!
Discover this DeFi diamond before the next surge
Sell
36
PLX
Protalix BioTherapeutics
Last Price:
1.15
Seasonality Move:
0.76%
7 Day Trial
ALL ACCESS PASS
$
7
MarketBeat Alert: Escape the market madness with 7 stocks to buy and hold
The result is a select group of high-quality blue-chip stocks.Protalix BioTherapeutics Price Quote
$1.15
+0.01 (+-0.86%)
(Updated: May 4, 2024 at 6:32 AM ET)
Protalix BioTherapeutics Key Stats
Sell
36
Protalix BioTherapeutics (PLX)
is a Sell
Day range:
$1.13 - $1.19
52-week range:
$1.09 - $3.55
Dividend yield:
0%
P/E ratio:
12.67
P/S ratio:
1.35
P/B ratio:
2.48%
Volume:
231.5K
Avg. volume:
374.4K
1-year change:
-63.81%
Market cap:
$83.3M
Revenue:
$65.5M
EPS:
$0.02
How Much Does Protalix BioTherapeutics Make?
-
How Much Are Protalix BioTherapeutics's Sales Annually?
PLX Revenues are $65.5M -
How Much Profit Does Protalix BioTherapeutics's Make A Year?
PLX net income is $8.3M
Is Protalix BioTherapeutics Growing As A Company?
-
What Is Protalix BioTherapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.22% -
What Is Protalix BioTherapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Protalix BioTherapeutics Stock Price Performance
-
Did Protalix BioTherapeutics Stock Go Up Last Month?
Protalix BioTherapeutics share price went down by -8.06% last month -
Did PLX's Share Price Rise Over The Last Year?
PLX share price fell by -63.81% over the past 1 year
What Is Protalix BioTherapeutics 52-Week High & Low?
-
What Is Protalix BioTherapeutics’s 52-Week High Share Price?
Protalix BioTherapeutics has traded as high as $3.55 over the past 52 weeks -
What Is Protalix BioTherapeutics’s 52-Week Low Share Price?
Protalix BioTherapeutics has traded as low as $1.09 over the past 52 weeks
Protalix BioTherapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Protalix BioTherapeutics?
-
How Much Debt Does Protalix BioTherapeutics Have?
Total long term debt quarterly is $20.3M -
How Much Cash Does Protalix BioTherapeutics Have?
Cash and short term investments quarterly total is $44.6M -
What Is Protalix BioTherapeutics’s Book Value Per Share?
Book value per share is 0.46
Is Protalix BioTherapeutics Cash Flow Positive?
-
What Is PLX Cash Flow From Operations?
Cash flow from operations (TTM) is -$1.3M -
What Is Protalix BioTherapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $24.7M -
What Is Protalix BioTherapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$16.7M
Protalix BioTherapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
PLX return on invested capital is 19.05% -
What Is Protalix BioTherapeutics Return On Assets?
ROA measures how assets are converting to revenues and is 10.86% -
What Is PLX Return On Equity?
ROE is a measure of profitability and is 41.07%
Protalix BioTherapeutics Earnings Date & Stock Price
-
What Is Protalix BioTherapeutics's Stock Price Today?
A single share of PLX can be purchased today for 1.14 -
What Is Protalix BioTherapeutics’s Stock Symbol?
Protalix BioTherapeutics trades on the nyam under the ticker symbol: PLX -
When Is Protalix BioTherapeutics’s Next Earnings Date?
The next quarterly earnings date for Protalix BioTherapeutics is scheduled on May 3, 2024 -
When Is PLX's next ex-dividend date?
Protalix BioTherapeutics's next ex-dividend date is May 26, 2020 -
How To Buy Protalix BioTherapeutics Stock?
You can buy Protalix BioTherapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Protalix BioTherapeutics Competitors
-
Who Are Protalix BioTherapeutics's Competitors?
Below is a list of companies who compete with Protalix BioTherapeutics or are related in some way:
Protalix BioTherapeutics Dividend Yield
Data Unavailable
Protalix BioTherapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0% |
| Revenue: | 21.69% | 28.73% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 13.00 |
| Upside from Last Price: | 1040.35% |